NYSE - Delayed Quote USD

CONMED Corporation (CNMD)

Compare
67.50 +0.05 (+0.07%)
At close: June 27 at 4:00 PM EDT
67.50 0.00 (0.00%)
After hours: June 27 at 5:16 PM EDT
Loading Chart for CNMD
DELL
  • Previous Close 67.45
  • Open 67.43
  • Bid --
  • Ask --
  • Day's Range 66.77 - 67.88
  • 52 Week Range 61.05 - 138.29
  • Volume 219,403
  • Avg. Volume 496,224
  • Market Cap (intraday) 2.079B
  • Beta (5Y Monthly) 1.43
  • PE Ratio (TTM) 25.86
  • EPS (TTM) 2.61
  • Earnings Date Jul 24, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 0.80 (1.19%)
  • Ex-Dividend Date Jun 14, 2024
  • 1y Target Est 94.86

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

www.conmed.com

4,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CNMD

View More

Performance Overview: CNMD

Trailing total returns as of 6/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CNMD
38.05%
S&P 500
14.95%

1-Year Return

CNMD
48.21%
S&P 500
26.66%

3-Year Return

CNMD
51.00%
S&P 500
28.08%

5-Year Return

CNMD
15.98%
S&P 500
88.17%

Compare To: CNMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNMD

View More

Valuation Measures

Annual
As of 6/27/2024
  • Market Cap

    2.08B

  • Enterprise Value

    3.04B

  • Trailing P/E

    25.86

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.69

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    2.41

  • Enterprise Value/EBITDA

    14.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.53%

  • Return on Assets (ttm)

    3.68%

  • Return on Equity (ttm)

    10.25%

  • Revenue (ttm)

    1.26B

  • Net Income Avi to Common (ttm)

    82.35M

  • Diluted EPS (ttm)

    2.61

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    33.85M

  • Total Debt/Equity (mrq)

    115.93%

  • Levered Free Cash Flow (ttm)

    168.06M

Research Analysis: CNMD

View More

Company Insights: CNMD

Research Reports: CNMD

View More

People Also Watch